Clinical & Molecular Biomedicine (CMB) is published by Editory-Press LLC. The journal's editorial office operates as a structural unit of Editory-Press LLC and is not a separate legal entity or an independently operating financial entity. The publisher administers the journal's financial, accounting, and operational activities in accordance with applicable legislation and the journal's governing regulations.

Clinical & Molecular Biomedicine is financially and operationally supported by Editory-Press LLC. The publisher provides resources necessary for the journal's editorial and publishing activities, including operational funding, office facilities, communication services, computer equipment, and other required infrastructure.

Under the journal's governing regulations, additional lawful sources of financial support may include:

• journal subscription income, where applicable;
• lawful advertising or publishing-related commercial activities, where applicable;
• grants;
• sponsorship;
• voluntary donations and charitable contributions; and
• other sources permitted under applicable legislation.

The existence of any such financial support does not confer editorial influence over the journal.

Clinical & Molecular Biomedicine does not currently charge authors submission fees, article processing charges (APCs), publication fees, or other mandatory author charges.

Detailed information is provided in the journal's Article Processing Charges and Author Fees policy.

Financial support, sponsorship, donations, advertising, grants, or other sources of revenue do not influence editorial decisions.

The publisher, sponsors, donors, advertisers, and other financial contributors may not interfere with the peer-review process or with decisions concerning the acceptance, revision, rejection, or publication of individual manuscripts. The journal's governing regulations expressly prohibit sponsors from interfering with the professional activities of the journal and its editorial staff.

Editorial decisions are made independently on the basis of scientific quality, originality, methodological soundness, relevance, and compliance with the journal's editorial and ethical standards.

Clinical & Molecular Biomedicine is committed to transparency regarding its business model and sources of financial support.

Any material change to the journal's funding model, author-fee structure, sponsorship arrangements, advertising practices, or other significant revenue sources will be clearly disclosed on the journal website.